Integrated multi-biomarker responses of juvenile rainbow trout (Oncorhynchus mykiss) to an environmentally relevant pharmaceutical mixture

• Main Authors: Mahaut Beghin, Mélodie Schmitz, Stéphane Betoulle, Olivier Palluel, Sébastien Baekelandt, Syaghalirwa N.M. Mandiki, Erin Gillet, Katherine Nott, Jean-Marc Porcher, Christelle Robert, Sébastien Ronkart, Patrick Kestemont
• Format: Article
• Language: English
• Published: Elsevier 2021-09-01
• Series: Ecotoxicology and Environmental Safety
• Subjects: Drugs; Cocktail; Fish; Immunity; Neurotoxicity; IBR
• Online Access: http://www.sciencedirect.com/science/article/pii/S0147651321005662

Pharmaceuticals are emerging pollutants of concern for aquatic ecosystems where they are occurring in complex mixtures. In the present study, the chronic toxicity of an environmentally relevant pharmaceutical mixture on juvenile rainbow trout (Oncorhynchus mykiss) was investigated. Five pharmaceuticals (paracetamol, carbamazepine, diclofenac, naproxen and irbesartan) were selected based on their detection frequency and concentration levels in the Meuse river (Belgium). Fish were exposed for 42 days to three different concentrations of the mixture, the median one detected in the Meuse river, 10-times and 100-times this concentration. Effects on the nervous, immune, antioxidant, and detoxification systems were evaluated throughout the exposure period and their response standardized using the Integrated Biomarker Response (IBRv2) index. IBRv2 scores increased over time in the fish exposed to the highest concentration. After 42 days, fish exposed to the highest concentration displayed significantly higher levels in lysozyme activity (p < 0.01). The mixture also caused significant changes in brain serotonin turnover (p < 0.05). In short, our results indicate that the subchronic waterborne exposure to a pharmaceutical mixture commonly occurring in freshwater ecosystems may affect the neuroendocrine and immune systems of juvenile rainbow trout.